Ligne de temps
Armelle Phalipon
Chef(fe) de Groupe
07 oct. 2022
27 avr. 2022
publication
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.
Lire plus17 mars 2022
25 août 2018
25 août 2018
patent
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri (SF6)
Lire plus25 août 2018
patent
Glycoconjugates and use thereof as vaccines against Shigella flexneri serotype 3a and X
Lire plus25 août 2018
patent
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri
Lire plus25 sept. 2017
24 avr. 2017
03 juin 2016
27 mars 2016
27 mars 2016
08 oct. 2015
project
GPF Vaccinology Call 1: Open call for new ideas for cutting-edge science investigations in vaccinology.
Lire plus08 oct. 2015
project
GPF Vaccinology Call 2: Accelerating Preclinical Development of Vaccine Candidates
Lire plus07 oct. 2015
26 sept. 2015
12 sept. 2015
04 juin 2015
01 mars 2015
09 févr. 2015
28 juin 2014
publication
Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity
Lire plus02 juin 2014
06 mars 2014
24 mai 2011
publication
Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance
Lire plus21 avr. 2011
publication
The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism.
Lire plus01 janv. 2011
28 oct. 2010
publication
Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy
Lire plus20 janv. 2010
publication
Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity
Lire plus27 mars 2009
publication
Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a
Lire plus15 févr. 2009
publication
A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection
Lire plus10 juil. 2008
publication
Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?
Lire plus18 avr. 2007
09 janv. 2007
publication
Shigella’s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
Lire plus26 oct. 2005
publication
Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a
Lire plus20 févr. 2004
publication
Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit
Lire plus18 août 2003
publication
Conformational studies of the O-specific polysaccharide of Shigella flexneri 5a and of four related synthetic pentasaccharide fragments using NMR and molecular modeling
Lire plus01 juin 2003
publication
Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells
Lire plus01 févr. 2003
publication
Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins
Lire plus01 janv. 2003
publication